Preventing exposure to moulds  by Carreras, E.
REVIEW
Preventing exposure to moulds
E. Carreras
BMT Unit, Haematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain
ABSTRACT
Invasive fungal infections are a major cause of morbidity and mortality in patients with profound
neutropenia or with severe immunosuppression. As Aspergillus and other mould species are ubiquitous,
numerous reservoirs have been identiﬁed. Mould infection in susceptible patients results basically from
respiratory exposure to conidia present in the air and on objects that surround the patients. In this
review, protective environmental measures directed at airborne transmission and other less frequent
mechanisms of transmission of moulds, as well as their effectiveness, are analysed.
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INTRODUCTION
Invasive fungal infections (IFIs) are a major cause
of morbidity and mortality in patients with
profound neutropenia or with severe immuno-
suppression. Most IFIs are caused by Aspergillus
species [1]. During the past decade, multiple
changes in the management of patients have
affected the epidemiology of IFIs [2]. The inci-
dence of invasive aspergillosis (IA) has progres-
sively increased, and infections caused by other
moulds, e.g., Fusarium species, Zygomycetes and
dematiaceous fungi, have emerged [3]. Despite
the development of new and effective antifungal
agents, the mortality rates associated with these
fungal infections remain very high, especially
among patients receiving allogeneic stem-cell
transplants (SCTs) [1,2].
Aspergillus and other mould species are ubi-
quitous and are found in soil, air, water, food, and
decaying material. Given the ubiquitous nature of
moulds, numerous reservoirs have been identi-
ﬁed: unﬁltered air, ventilation and air-condition-
ing systems, dust from construction ⁄ renovation
sites, carpets, bathrooms, pillows, ornamental
plants and computer fans, among others. Conidia
of moulds are very well-adapted to airborne
dissemination from the previously mentioned
reservoirs, and this is how at-risk patients acquire
infection [4,5]. Normally, we breathe in 100–200
spores ⁄day that potentially can colonise suscept-
ible hosts. Only those with severe neutropenia or
immunosuppression will develop an invasive
infection [4].
PREVENTION
Mould infection in susceptible patients results
primarily from respiratory exposure to or direct
contact with fungal spores [6]. Infections acquired
through the intestinal tract or the skin are
unusual, so protective environmental measures
directed at mechanisms of transmission other
than airborne transmission have a low impact on
IFI prevention. Construction and ⁄ or renovation
and suboptimal maintenance, cleaning and pro-
tection of the environment have been identiﬁed as
the most important causes of IA [7–9]. Multiple
outbreaks reported in the literature have illustra-
ted the risk associated with these situations
[10,11]. Although a nosocomial origin is the case
for most IFIs, a major concern is the question of
whether, in an individual patient, the infection
was acquired in the hospital or in the community.
This is an extremely relevant point, because our
most energetic efforts to prevent nosocomial
infections will not prevent IFIs acquired in the
community. The incubation period in the case of
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these infections is unknown but is estimated to be
between 2 days and 3 months. For that reason, it
is not possible to establish with absolute certainty
whether an IFI is nosocomial or acquired after
hospital discharge [12]. Similarly, an IFI diag-
nosed soon after hospital admission may have
been acquired either inside or outside the hospi-
tal. Molecular methods can be crucial for eluci-
dating the origin of these infections. If the
deﬁnition of hospital-acquired infection is the iso-
lation of the same fungal strain from the patient
and the hospital environment, only 40% of cases
of IA appear to be nosocomial [13]. Consequently,
all the measures described below will not be ade-
quate to prevent all IFIs unless they are applied
not only in the hospital setting, but also at home
and during transportation between the two.
The recommendations analysed in this review
come mainly from the quoted guidelines in
[7,8,14–16].
PATIENTS WHO REQUIRE A
PROTECTIVE ENVIRONMENT
Protective environmental measures are expensive
and their efﬁcacy has not been tested in all risk
situations. Owing to the high risk of IFIs in
persons receiving solid-organ transplants, and
especially in those with haematological diseases,
they constitute the population that most warrants
preventive environmental measures [1]. Among
patients with haematological diseases, the highest
risk of IFIs is observed in two groups. The ﬁrst
group includes those with anticipated prolonged
and severe neutropenia, mainly leukaemia
patients undergoing remission–induction treat-
ment or patients receiving autologous or allogeneic
SCTs using marrow stem cells [3,12]. The CDC
(1994) and a Spanish task force (2000) [14,16]
recommend preventive measures in patients with
less than 100 neutrophils ⁄mm3 for a period of
1 week or less than 1000 neutrophils ⁄mm3 for
2 weeks [16]. In 2003, the CDC, reasonably,
reduced the neutrophil count to less than
500 ⁄mm3 for a period of 2 weeks [16]. The second
group includes those with severe immunosup-
pression, as occurs in allogeneic SCT recipients
with an extensive graft vs. host disease that
requires intensive immunosuppressive therapy
[3,12]. The cost-effectiveness of protective envi-
ronmental measures in haematological patients
with a lower risk of IFIs should be analysed.
ISOLATION AND BARRIER
PRECAUTIONS
Although many hospitals use reverse protective
isolation measures to improve efﬁcacy in the
prevention of nosocomial fungal infections in the
case of high-risk patients, the degree of efﬁcacy
has not been clearly deﬁned in most cases.
Reverse isolation is implemented to prevent
patients from acquiring communicable diseases
or pathogenic microorganisms from the people
surrounding them [9]. These patients should be
placed in single-patient rooms, and standard
precautions should be applied (hand washing
and wearing of appropriate gloves, masks and
gowns) during activities that can generate spla-
shes or sprays of blood, body ﬂuids, secretions or
excretions, or cause soiling of clothing [8,16,17].
For other situations, the usefulness of these
measures (except hand washing) is doubtful, but
many centres recommend them [9]. In other
settings, head or shoe covers and clean or sterile
gowns are used exclusively in sterile laminar
airﬂow (LAF) rooms [8,9].
HAND HYGIENE
Hand washing continues to be the single most
critical and effective procedure for preventing
infections [8,9,15]. Everyone (family, friends and
particularly healthcare workers) should wash
their hands before entering the patient’s room,
having direct contact with them, preparing food,
manipulating catheters or handling wounds.
Additionally, they should wash their hands after
leaving the patient’s room, after touching non-
intact skin or wounds, secretions, excretions
or items in contact with stool, after gardening or
touching plants or dirt, and after touching pets
or animals [15].
Alcohol-based antiseptics (60–95% alcohol) are
recommended nowadays for hand washing. They
are effective against Gram-positive and Gram-
negative bacteria, Mycobacterium tuberculosis, vir-
uses and various fungi. These solutions provide
easy access to hand hygiene and facilitate the
adherence of healthcare workers to recommended
procedures. However, as adherence to these
procedures is poor (average 40%), additional
strategies to promote hand hygiene as well as
motivational ⁄ educational programmes should be
established [15].
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PERSONAL EFFECTS, EQUIPMENT,
FLOWERS, PLANTS AND TOYS
Ideally, the personal effects of patients should be
limited to those that can be disposed of or easily
cleaned, in an attempt to avoid airborne dissem-
ination or direct fungal exposure. Bed sheets and
blankets, towels, personal clothing, patient appa-
rel, uniforms, scrub suits, gowns and drapes for
surgical procedures should be washed in hot
water (at least 71C) for a minimum of 25 min.
The use of chlorine bleach gives an extra margin
of safety [7]. Non-sterile tongue depressors that
have been associated with invasive infections
due to Rhizopus microsporus should not be used
as splints for catheters in children [18]. Because
Aspergillus species (and other moulds) have been
isolated from the soil of ornamental plants and
the surface of dried and fresh ﬂowers, they
should not be allowed in the patients’ rooms.
Only toys, games and videos that can be kept
clean and disinfected are acceptable. As smoking
of marijuana might be associated with invasive
pulmonary aspergillosis among immunocompro-
mised individuals, high-risk patients should
avoid it [19].
PERSONAL HYGIENE
Daily showers have always been recommended
to optimise skin care in high-risk patients.
However, recent studies have demonstrated that
spores of Aspergillus species, Fusarium species and
other moulds can be recovered from hospital
water supplies. Additionally, air sampling car-
ried out in patients’ rooms showed lower mould
counts than those obtained in bathrooms, and
lower counts in dry air than in humid air. Thus,
showering seemed to result in aerosolisation of
Aspergillus and other mould spores and was a
potential source of infection [20]. Other authors
have recovered ﬁlamentous fungi from all water
samples analysed (e.g., Aspergillus from 60% of
tap water samples) [21]. Consequently, at the
present time, some authors recommend the use
of sterile sponge baths for very high-risk
patients. Alternatively, cleaning of the bathroom
before taking a shower should include ﬂoors,
walls, sink area, inside and outside the toilet,
faucets, showerheads, mirrors and other surfaces
[22].
FOOD, WATER AND BEVERAGES
Although fungal infections transmitted by inges-
tion seem to be infrequent, measures to prevent
the acquisition of bacterial and parasitic agents
could also be useful in preventing mould acqui-
sition. Sterile diets have been progressively aban-
doned in favour of low-microbial diets, which are
easier to prepare and more ﬂavourful. Food
should be correctly stored, manipulated and
cooked. Different raw foods (poultry, meat, ﬁsh,
vegetables) should be prepared on separate sur-
faces, and hands, cutting boards, knives and other
tools should be washed in warm soapy water
before coming into contact with other foods. All
food should be adequately cooked, according to
the temperature required for each (60–80C) [8].
Prepared foods should be refrigerated if not
immediately consumed and reheated before ser-
ving. Fresh unpasteurised products, especially
cheeses containing moulds, and mouldy or
outdated food should be avoided. Fresh salads
or vegetables should be washed under running
tap water (if correctly chlorinated) before being
served; the same measures should be taken with
fresh fruits unless they can be peeled [8,9].
Hepatic mucormycosis has been described in a
patient using naturopathic products; conse-
quently, these products should be avoided
[8,23].
Water provided by municipal wells (tested
daily), boiled water (if controlled tap water is
not available), most bottled waters and canned or
pasteurised beverages can be consumed by high-
risk patients. Walking, wading, swimming and
playing in recreational areas (with human or
animal waste) should be avoided, as well as
water, ice or fruit drinks from non-controlled
wells [8]. Ideally, hospital water distribution
systems should be maintained at a low water
temperature of <20C and a hot water tempera-
ture of >51C, and measures to minimise the risk
of scalding should be explored [7].
PETS AND OTHER ANIMALS
Although all domestic mammals and birds and
numerous wild species can have aspergillosis,
animals are an infrequent source of human con-
tamination. Blastomycosis transmitted by dogs in
some geographical areas and dermatomycosis
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transmitted by rabbits, rodents, primates and
dogs are the most well-documented mycoses of
animal origin [7]. Preventive measures include
minimising direct contact with animals and their
excrement, especially when they are ill. If this
contact cannot be avoided, gloves should be used
and hands correctly washed afterwards [8].
ROOM VENTILATION
Modern ventilation and ﬁltration systems dra-
matically reduce environmental counts of Asperg-
illus species and cases of invasive disease [24–29].
Table 1 shows the most relevant studies that have
focused on neutropenic and SCT patients.
Nowadays, most units for high-risk patients are
provided with HEPA ﬁlters that remove 99.97%
of particles greater than 0.3 lm in size. These
ﬁlters eliminate not only conidia but also bacteria
and viruses associated with particles of dust
suspended in the air. However, prevention of
nosocomial aspergillosis involves not only the use
of ﬁlters but also the proper installation, use and
maintenance of ventilation systems and the elim-
ination of exposure to fungal spores generated by
construction and renovation [7]. Table 2 lists the
most relevant measures that should be associated
with HEPA ﬁlters [7]. In Spain, recommendations
for environmental controls in high- and interme-
diate-risk areas (operating rooms, neutropenic
and SCT areas, intensive care units) were pub-
lished in 2000 by the SEMPSP and the INSALUD
[14].
LAF rooms contain HEPA-ﬁltered air that
moves with a parallel, unidirectional ﬂow.
Although preferred during the 1980s, the theor-
etical advantages of this form of protective envi-
ronment have never been proved, and the current
guidelines do not recommend LAF [7–9].
Portable HEPA ﬁlters are sometimes used as
adjuncts to the primary ventilation system (at
home and in some hospitals) and seem to be
effective if correctly placed in the centre of the
patient’s room [7–9].
Despite a lack of deﬁnitive data supporting
their use, most centres employ FFP3 (also known
as N95) masks when patients are outside their
rooms, outside the hospital, near construction
sites, or in tree-pruning areas [8,9]. When cor-
rectly placed on trained patients, FFP3 masks
reduce aerosol exposure by 90%. However, not all
patients are able to correctly wear and tolerate
these masks [30,31]. Standard surgical masks do
not provide protection against mould spores and
are not recommended for this purpose.
Hospital construction and renovation have
been associated with an increased risk of nosoco-
mial fungal infections. Therefore, the responsible
individuals should follow published recommen-
dations regarding environmental controls. The
most relevant are summarised in Table 2 [7].
EFFICACY OF PROTECTIVE
ENVIRONMENTAL MEASURES
Very few studies have evaluated the effectiveness
of preventive measures for high-risk patients [32].
Early prospective, randomised studies of protect-
ive environments that analysed both isolation and
decontamination procedures showed a signiﬁcant
Table 1. Environmental counts of
Aspergillus species and cases of inva-
sive disease before and after the
adoption of air ﬁltration measures
in units for neutropenic and stem-
cell transplant patients
Author Period analysed CFU ⁄m3 Aspergillosis
Rhame et al. (1984) [24] Pre-HEPA 2.0 15%
Post-HEPAa 0.8 8%
Post-HEPAb 0.14 4%
Opal et al. (1986) [25] Pre-HEPA 1.2 5.5 ⁄ year
Post-HEPA 0.008 1 ⁄ year
Sherertz et al. (1987) [26] Pre-LAF 0.2–0.4 33%
Post-LAF 0.009 0%
Arnow et al. (1991) [27] Pre-HEPA 3.3 1.9%
Post-HEPA 0.005 0.38%
Loo et al. (1996) [28] Pre-HEPA 6.7 9.8 ⁄ 1000 days
Post-HEPA 0 2.9 ⁄ 1000 days
Withington et al. (1998) [29] Pre-HEPA 2.9 7.1%
Post-HEPA 0.02 0
aHEPA ﬁlters in patients’ rooms.
bIn patients’ rooms and in unit corridors.
LAF, laminar airﬂow.
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reduction in infections but no impact on survival
[33,34]. In addition to these early studies and
those evaluating the role of HEPA ﬁlters in
reducing IA incidence (Table 1), only a single
multicentre retrospective analysis, performed by
the International Bone Marrow Transplant Regis-
try (IBMTR), has been published [35]. This study
focused on allogeneic SCT in HLA-identical sib-
lings or in unrelated volunteer donors, and
compared patients placed in conventional pro-
tective isolation with a group placed in HEPA-
ﬁltered or LAF rooms. They found a signiﬁcantly
higher 1-year survival rate and decreased trans-
plant-related mortality in the ﬁrst 100 days post-
SCT in the group treated in HEPA ⁄LAF rooms.
The main explanation for this reduction was a
lower incidence of bacterial and fungal infections.
However, two recent publications analysed the
outcome of more than 300 SCT patients (related or
unrelated donors), without pharmacological or
environmental preventive measures. In both
cases, the incidence of IFI was very low (<1%
and 2.2%, respectively) [36,37]. A possible explan-
ation could be that the study centres were located
in Calgary and Stockholm, respectively. It is well-
known that patients treated in warm climates
may be at higher risk of exposure to airborne
fungal spores [38]. Consequently, the cold and
dry climate of these cities may provide protection
against mould infection. Similarly, the IBMTR
study showed an inverse correlation between
latitude and transplant-related mortality [35].
ENVIRONMENTAL SAMPLING
By 1970, the CDC and the American Hospital
Association recommended discontinuation of
routine environmental cultures because the rates
of nosocomial infection did not correlate with
microbial contamination of air and environmental
surfaces, since standards of microbial environ-
mental contamination were lacking [39]. Addi-
tionally, microbiological sampling of air, water
and inanimate surfaces is an expensive and time-
consuming process that is complicated by many
variables in protocol, analysis and interpretation.
It is therefore indicated in only four situations [7]:
(i) to support an investigation of an outbreak
when environmental reservoirs or fomites could
be implicated; (ii) for research purposes to pro-
vide new information about the spread of health-
care-associated diseases; (iii) to monitor a
potentially hazardous environmental condition
(conﬁrm the presence of a hazardous chemical or
biological agent); and (iv) to evaluate the effects of
a change in infection control practice for quality
assurance or to ensure that equipment or systems
perform according to speciﬁcations and expected
outcomes [7].
In the context of air sampling, liquid impinger
and solid impactor samplers are the most
Table 2. Summary of the most relevant ventilation
requirements for protective environment rooms
Room facilities
Private room
Central or point-of-use HEPA ﬁlter (LAF is not
necessary)
Air in patient room with positive pressure (>2.5 Pa)
in relation to corridor (or anteroom)
As a minimum, 12 air changes per hour
Air intake on one side of the room, ﬂowing across
patient’s bed; exhausts at opposite side of the room
Adequate temperature (22–24C) and humidity
(30–60%)
Humidiﬁers placed upstream from the ﬁnal ﬁlter
Windows, ceiling and electrical outlets correctly sealed;
self-closing doors
Carpets and other dust sources eliminated
Fresh or dry ﬂowers or potted plants eliminated
False ceilings; avoid
Other measures
Minimise the time that patients are outside the room
Use FFP3 (N95) masks when patients are outside
the room
Cleaning
Rooms should be cleaned ‡1 times ⁄day
Exhaust vents, windows sills and horizontal surfaces
should be cleaned with cloths and mop heads using
an approved disinfectant; cloths and mop heads
should be changed in each room
Avoid all vacuuming (if necessary, use vacuum
cleaners with HEPA ﬁlters)
Bathroom should be thoroughly cleaned immediately
before patient showers (ﬂoors, walls, sink, toilet,
mirror and any other surfaces, faucets and
showerheads (best removed))
Water leaks should be cleaned up and repaired
as soon as possible
Construction ⁄ renovation
Construct rigid, dust-proof barriers with airtight seals
between patients and the work site
If these barriers cannot be created, move high-risk
patients away from the work site
Direct pedestrian trafﬁc near the work site away from
patients
Work sites should have negative air pressure with
respect to patient care areas
Renovated areas should be correctly cleaned before
patients are admitted
LAF, laminar airﬂow.
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practical for analysing bacteria, particles and
fungal spores, because they can sample large
volumes of air in relatively short periods of
time. Results obtained from either sampling
device can be expressed as organisms or parti-
cles per unit volume of air (CFU ⁄m3). The use of
settle plates (i.e., the sedimentation or deposi-
tional method) is not recommended when samp-
ling air for fungal spores, because single spores
can remain suspended in the air indeﬁnitely
[7,40].
Concerning water sampling, specimens are not
‘static’ at ambient temperature, and potential
changes in both numbers and types of microbial
populations can occur during transport. Conse-
quently, water samples should be sent to the
laboratory cold (c. 4C) and tested as soon as
practical after collection (<24 h). The minimum
volume to collect is 100 mL. Sampling from a tap
requires ﬂushing of the water line before collec-
tion [7].
Concerning surface sampling, the media, rea-
gents and equipment required for this are avail-
able from any well-equipped microbiology
laboratory. Effective sampling of surfaces requires
moisture, either already present on the surface to
be sampled, or provided by moistened swabs,
sponges, wipes, agar surfaces or membrane ﬁlters
[7].
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